AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Thomas Brunner

Thomas Brunner

Otto Von Guericke Universität Magdeburg - Magdeburg / Germany
Medical and Health Sciences / Radiation Oncology
AD Scientific Index ID: 1762477
Otto von Guericke University of Magdeburg
person_outline Thomas Brunner's MOST POPULAR ARTICLES
1-) Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 Journal of Clinical Oncology 37 (34), 3212-3222, 2019
2-) Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation Cell death & disease 3 (12), e441-e441, 2012
3-) ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in … BMC cancer 16 (1), 503, 2016
4-) Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized … Strahlentherapie und Onkologie 191 (1), 7-16, 2015
5-) Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … JAMA oncology 8 (1), e215445-e215445, 2022